Fingerprint
Dive into the research topics of 'A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: The ACT III study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: The ACT III study
James Schuster, Rose K. Lai, Lawrence D. Recht, David A. Reardon, Nina A. Paleologos, Morris D. Groves, Maciej M. Mrugala, Randy Jensen, Joachim M. Baehring, Andrew Sloan, Gary E. Archer, Darell D. Bigner, Scott Cruickshank, Jennifer A. Green, Tibor Keler, Thomas A. Davis, Amy B. Heimberger, John H. Sampson
Research output: Contribution to journal › Article › peer-review
316
Scopus
citations